Identification and evaluation of 4-anilinoquin(az)olines as potent inhibitors of both dengue virus (DENV) and Venezuelan equine encephalitis virus (VEEV).


Journal

Bioorganic & medicinal chemistry letters
ISSN: 1464-3405
Titre abrégé: Bioorg Med Chem Lett
Pays: England
ID NLM: 9107377

Informations de publication

Date de publication:
15 11 2021
Historique:
received: 12 08 2021
revised: 22 09 2021
accepted: 01 10 2021
pubmed: 9 10 2021
medline: 8 1 2022
entrez: 8 10 2021
Statut: ppublish

Résumé

There is an urgent need for novel strategies for the treatment of emerging arthropod-borne viral infections, including those caused by dengue virus (DENV) and Venezuelan equine encephalitis virus (VEEV). We prepared and screened focused libraries of 4-anilinoquinolines and 4-anilinoquinazolines for antiviral activity and identified three potent compounds. N-(2,5-dimethoxyphenyl)-6-(trifluoromethyl)quinolin-4-amine (10) inhibited DENV infection with an EC

Identifiants

pubmed: 34624490
pii: S0960-894X(21)00634-X
doi: 10.1016/j.bmcl.2021.128407
pii:
doi:

Substances chimiques

Aniline Compounds 0
Antiviral Agents 0
Quinazolines 0
anilinoquinazoline 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

128407

Subventions

Organisme : Wellcome Trust
ID : 106169/ZZ14/Z
Pays : United Kingdom

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Sirle Saul (S)

Department of Medicine, Division of Infectious Diseases and Geographic Medicine, and Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.

Pei-Tzu Huang (PT)

Department of Medicine, Division of Infectious Diseases and Geographic Medicine, and Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.

Shirit Einav (S)

Department of Medicine, Division of Infectious Diseases and Geographic Medicine, and Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address: seinav@stanford.edu.

Christopher R M Asquith (CRM)

Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address: chris.asquith@unc.edu.

Articles similaires

Animals Swine Antiviral Agents Swine Diseases Coronavirus Infections
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol
Humans Carcinoma, Hepatocellular Liver Neoplasms Aged United States

Classifications MeSH